Open Endoscopic Vessel Harvesting System Offers Improved Ergonomics

A novel open carbon dioxide (CO2) endoscopic vessel harvesting (EVH) system can significantly lessen the complication of clot formation, when compared with a sealed EVH system.

The VascuClear EVH system is a truly open CO2 system, and thus is not reliant on sealed gas insufflation and carries little to no risk of CO2 embolism or intraluminal clot formation. A precision bipolar design offers several improvements, including an easy-to-use textured button configuration to provide a better feel and grip, and spring-loaded controls to return the jaw to a neutral position when released. A bright tip on the jaw improves visibility, and handles inside the harvesting tunnel provide an improved ergonomic feel, keeping cords out of the way. The system also operates at a low temperature, minimizing thermal spread.

Other features include greater flexibility, and a smooth cut and seal that require no additional "tugging” on the vessel. The proprietary Bonchek Vein Distention system distends and irrigates a vein graft to a predetermined level to avoid over-distention of the harvested vessel. The VascuClear system is delivered in visibly clear, recyclable packaging and is conveniently organized and easy to open for immediate use. The VascuClear EVH system is a product of the Sorin Group (Milan, Italy).

"The introduction of VascuClear provides clinicians with the newest tool for minimally invasive endoscopic vessel harvesting and strengthens our comprehensive line of cardiovascular products and services,” said Michel Darnaud, president of the cardiopulmonary and intercontinental business units at the Sorin Group.

EVH uses specialized instruments to view and remove a healthy blood vessel for harvesting during coronary artery bypass graft (CABG) surgery, with minimal trauma to the vessel or surrounding tissues. In clinical studies, EVH has shown important benefits, including a reduced risk of infection and wound complications; less postoperative pain and swelling; and faster recovery with minimal scarring. The reduction in pain allows patients to get back on their feet and return to normal mobility much sooner, along with a reduced length of hospital stay.

Related Links:
Sorin Group